Bamlanivimab Terminated Phase 4 Trials for Hospital Acquired Infections / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04748588Treatment of Nosocomial COVID-19